** Medical gloves and surgical gowns maker Ansell ANN.AX falls 1.3% to A$29.33
** Morgan Stanley factors in downside risk due to U.S. tariffs, despite ANN expecting to offset impacts through pricing
** Lowers PT to A$33.40 from A$37.20; retains 'equal-weight'
** Trims revenue growth for co's Industrial and Healthcare units, citing volume risk given slowing macroeconomic growth
** Cuts EPS forecast by 9% in FY26 and 11% in FY27; both below Visible Alpha consensus
** YTD, ANN down ~13%
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。